January 2009 Archives - Silence Therapeutics

News	Events
Publications	Companies
Clinical Trials

Silence Therapeutics announces its successful opposition to second European Patent in Kreutzer-Limmer patent family
0 Replies

January 21, 2009

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

January 19, 2009

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

January 15, 2009

Contine Reading & Discuss→

Posted in News and Events

Total Voting Rights
0 Replies

Contine Reading & Discuss→

Posted in News and Events

Change of address
0 Replies

January 12, 2009

Contine Reading & Discuss→

Posted in News and Events

Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines
0 Replies

Collegeville, Pa., & Hoersholm, Denmark, January 12, 2009 Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Santaris Pharma today announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris Pharma’s proprietary Locked Nucleic Acid (LNA) Drug Platform, which allows specific... Contine Reading & Discuss→

Posted in Companies | Tagged in | Santaris Posted in News | Tagged in | Santaris Posted in Other News | Tagged in | Santaris Posted in Syndicated | Tagged in | Santaris

European Patent Office grants Silence Therapeutics’ Patent on Target for Lead Compound Atu027
0 Replies

January 09, 2009

Contine Reading & Discuss→

Posted in News and Events

Gartmore takes significant stake in Silence Therapeutics plc
0 Replies

January 08, 2009

Contine Reading & Discuss→

Posted in News and Events

Silence Therapeutics’ partner Quark initiates next stage of clinical trials on DGF
0 Replies

Contine Reading & Discuss→

Posted in News and Events